Murine long-term repopulating ability is compromised by ex vivo culture in serum-free medium despite preservation of committed progenitors

被引:17
作者
Sekhar, M [1 ]
Yu, JM [1 ]
Soma, T [1 ]
Dunbar, CE [1 ]
机构
[1] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
来源
JOURNAL OF HEMATOTHERAPY | 1997年 / 6卷 / 06期
关键词
D O I
10.1089/scd.1.1997.6.543
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hematopoietic progenitor cells can be maintained and expanded ex vivo in standard or serum-free culture medium supplemented with a variety of stimulatory cytokines, The use of serum-free medium allows specification of reproducible and precise growth conditions optimal for various applications and is more acceptable from a safety and regulatory point of view, Human and murine committed progenitor cells have been shown to be equivalently or better supported by serum-free culture conditions in the presence of multicytokine combinations, but there is little information on the effects of such culture conditions on repopulating stem cells, We used a murine competitive repopulation model to assess the effect of serum-free versus serum-containing ex vivo culture on long-term reconstituting cells, Despite equivalent numbers of committed CFU-C and day 12 CFU-S present after 4 days of culture of murine marrow in serum-free or serum-containing conditions in the presence of IL-3, IL-6, and SCF, long-term reconstituting activity was significantly impaired by serum-free culture, These findings may have important implications for transplantation and gene therapy applications.
引用
收藏
页码:543 / 549
页数:7
相关论文
共 44 条
[11]   RETROVIRALLY MARKED CD34-ENRICHED PERIPHERAL-BLOOD AND BONE-MARROW CELLS CONTRIBUTE TO LONG-TERM ENGRAFTMENT AFTER AUTOLOGOUS TRANSPLANTATION [J].
DUNBAR, CE ;
COTTLERFOX, M ;
OSHAUGHNESSY, JA ;
DOREN, S ;
CARTER, C ;
BERENSON, R ;
BROWN, S ;
MOEN, RC ;
GREENBLATT, J ;
STEWART, FM ;
LEITMAN, SF ;
WILSON, WH ;
COWAN, K ;
YOUNG, NS ;
NIENHUIS, AW .
BLOOD, 1995, 85 (11) :3048-3057
[12]   Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics [J].
Emerson, SG .
BLOOD, 1996, 87 (08) :3082-3088
[13]  
GABRILOVE JL, 1993, BLOOD, V81, P909
[14]  
GREENBERG PL, 1991, BLOOD CELLS, V17, P344
[15]  
HARRISON DE, 1993, EXP HEMATOL, V21, P206
[16]  
HARRISON DE, 1980, BLOOD, V55, P77
[17]  
HAYLOCK DN, 1992, BLOOD, V80, P1405
[18]   REGULATION OF SOMATIC-CELL THERAPY AND GENE-THERAPY BY THE FOOD-AND-DRUG-ADMINISTRATION [J].
KESSLER, DA ;
SIEGEL, JP ;
NOGUCHI, PD ;
ZOON, KC ;
FEIDEN, KL ;
WOODCOCK, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (16) :1169-1173
[19]  
KOLLER MR, 1993, BLOOD, V82, P378
[20]  
Lansdorp P M, 1993, J Hematother, V2, P329, DOI 10.1089/scd.1.1993.2.329